SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-022122
Filing Date
2021-04-19
Accepted
2021-04-19 16:50:03
Documents
2
Period of Report
2021-04-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea139669_8k-180lifescienc.htm 8-K 20732
2 PRESS RELEASE DATED APRIL 19, 2021 ea139669_ex991-180lifescienc.htm EX-99.1 10838
  Complete submission text file 0001213900-21-022122.txt   32860
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 21835169
SIC: 2834 Pharmaceutical Preparations